Peter Greaney

Head Of Corporate Development at ADC Therapeutics - New Providence, NJ, US

Peter Greaney's Contact Details
HQ
908-731-5556
Location
Lausanne,Vaud,Switzerland
Company
ADC Therapeutics
Peter Greaney's Company Details
ADC Therapeutics logo, ADC Therapeutics contact details

ADC Therapeutics

New Providence, NJ, US • 250 - 499 Employees
BioTech/Drugs

ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.  These proprietary PBD-based ADCs are expected to provide a novel way to treat hematological cancers and solid tumors, address significant unmet medical needs, and improve the lives of patients with cancer. Our mission is to confront cancer with the full potential of our science to bring unique, targeted therapies and hope to patients and their families.

N/A
Details about ADC Therapeutics
Frequently Asked Questions about Peter Greaney
Peter Greaney currently works for ADC Therapeutics.
Peter Greaney's role at ADC Therapeutics is Head Of Corporate Development.
Peter Greaney's email address is ***@adctherapeutics.com. To view Peter Greaney's full email address, please signup to ConnectPlex.
Peter Greaney works in the Research industry.
Peter Greaney's colleagues at ADC Therapeutics are Stephane Henchoz, Genoveva Dragan, Sylvain Escolan, Niall McConnell, Sabine Soldan, Holt Robinson, Ranmali Wijayaratne and others.
Peter Greaney's phone number is 908-731-5556
See more information about Peter Greaney